Canada: a Region of Choice for Your Study Expansion
Successfully designing and conducting oncology trials is not getting easier. Many of the challenges we are facing in oncology research…
Successfully designing and conducting oncology trials is not getting easier. Many of the challenges we are facing in oncology research…
The nature and structure of our health care system in Canada results in patients being followed at the same center…
A biotech sponsor in the United States had targeted July 2015 for completion of enrollment for a Phase I dose-finding HER2+BrCa study.
Over the last decade, increased competition for finite patient populations in the U.S. have led many drug developers to expand…
I sat down recently with three of our Oncology Leads and asked them what questions they hear most often from…
In this interview, Dr. Quincy Chu, Medical Oncologist at the Cross Cancer Institute in Edmonton Alberta, discusses the ways in…
Given the increased focus on speed of activation for oncology studies, sponsors are under pressure to select top-performing investigative sites…
With the volume of medical data doubling every 5 years, the challenge has now become how to derive actionable insights…
Back in June of 2011, a leading U.S. biotech company, currently developing multiple therapeutic candidates, was planning a Phase I/II…